Pyxis Oncology (PYXS) Cash & Current Investments (2020 - 2026)
Pyxis Oncology (PYXS) recorded Cash & Current Investments of $33 million in Q2 2026, down 62.9% from $88.94 million a year earlier.
Powered by 
Analysis
Pyxis Oncology (PYXS) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Pyxis Oncology reported Cash & Current Investments of $66.86 million, down 47.3% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 52.6% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $126.93 million in FY2024 (+6.4%), $119.3 million in FY2023 (-33.5%), $179.29 million in FY2022 (-34.7%) and $274.74 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q4 2020.
- On a year-over-year basis, Cash & Current Investments rose in two of the last seven quarters, with an average decline of 31.1%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 75.7% in Q1 2022, against a decline of 62.9% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Pyxis Oncology | 107.83 Mn | -157.23 Mn | - | 33.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.00 Mn |
| Dec 31, 2025 | 66.86 Mn |
| Sep 30, 2025 | 76.26 Mn |
| Jun 30, 2025 | 88.94 Mn |
| Mar 31, 2025 | 105.43 Mn |
| Dec 31, 2024 | 126.93 Mn |
| Sep 30, 2024 | 144.82 Mn |
| Jun 30, 2024 | 155.72 Mn |
| Mar 31, 2024 | 157.03 Mn |
| Dec 31, 2023 | 119.30 Mn |
| Sep 30, 2023 | 132.97 Mn |
| Jun 30, 2023 | 142.66 Mn |
| Mar 31, 2023 | 149.35 Mn |
| Dec 31, 2022 | 179.29 Mn |
| Sep 30, 2022 | 198.54 Mn |
| Jun 30, 2022 | 223.36 Mn |
| Mar 31, 2022 | 247.09 Mn |
| Dec 31, 2021 | 274.74 Mn |
| Sep 30, 2021 | 133.48 Mn |
| Jun 30, 2021 | 142.47 Mn |
API Access
Pyxis Oncology Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PYXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PYXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PYXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();